Announce Date | 02/19/2025 |
EPS Normalized Actual | $6.15 (Beat by $0.39) |
EPS GAAP Actual | $6.15 (Beat by $0.39) |
Revenue Actual | $6.8109B |
Revenue Surprise | Beat by $6810.9M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 30.25 | 8.34 | 29.01207 | 31.98314 | 1 |
Dec 2028 | 28.5 | 8.86 | 27.93547 | 29.31985 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 5.07 | 5.07 | 6.8109B | 100% | 6810.9M |
FQ3 2024 (Sep 2024) | 3.26 | 3.26 | 5.8688B | 12.91% | 5868.8M |
FQ2 2024 (Jun 2024) | 1.78 | 1.78 | 5.6287B | 10.24% | 5628.7M |
FQ1 2024 (Mar 2024) | 0 | 0 | 0B | -INF% | 0M |
FQ3 2023 (Sep 2023) | 1.25 | 1.25 | 5.1114B | -1.29% | 5111.4M |
FQ2 2023 (Jun 2023) | 0.0524 | 0.0524 | 5.0525B | -99.5% | 5052.5M |
FQ1 2023 (Feb 2023) | 3.68 | 3.68 | 5.6048B | 100% | 5604.8M |
FQ4 2022 (Dec 2022) | 3.61 | 3.61 | 5.6048B | 100% | 5604.8M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 5.2174 | -- | 5.00614 | 5.47894 | 2 |
FQ3 2027 (Jul 2027) | 4.671 | -- | 4.48186 | 4.90515 | 2 |
FQ2 2027 (Jun 2027) | 4.671 | -- | 4.49755 | 4.85665 | 2 |
FQ1 2027 (Mar 2027) | 2.6345 | -- | 2.53667 | 2.73921 | 2 |
FQ4 2026 (Oct 2026) | 4.43695 | -- | 4.25729 | 4.65937 | 3 |
FQ3 2026 (Jul 2026) | 3.9492 | -- | 3.78929 | 4.14717 | 3 |
FQ2 2026 (Jun 2026) | 4.1142 | -- | 3.96143 | 4.27772 | 3 |
FQ1 2026 (Mar 2026) | 2.27445 | -- | 2.18999 | 2.36485 | 3 |
FQ4 2025 (Oct 2025) | 3.64588 | -39.06 | 3.49825 | 3.82864 | 3 |
FQ3 2025 (Sep 2025) | 3.73 | 12.6 | 3.55 | 3.87581 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 5.89B | -- | 5.71B | 6.12B | 2 |
FQ3 2027 (Jul 2027) | 5.83B | -- | 5.65B | 6.06B | 2 |
FQ2 2027 (Jun 2027) | 6.76B | -- | 6.57B | 6.97B | 2 |
FQ1 2027 (Mar 2027) | 6.69B | -- | 6.5B | 6.9B | 2 |
FQ4 2026 (Oct 2026) | 6.44B | -- | 6.24B | 6.69B | 2 |
FQ3 2026 (Jul 2026) | 6.34B | -- | 6.14B | 6.58B | 2 |
FQ2 2026 (Jun 2026) | 6.18B | -- | 6.01B | 6.37B | 2 |
FQ1 2026 (Mar 2026) | 5.83B | -- | 5.66B | 6.01B | 2 |
FQ4 2025 (Oct 2025) | 6.06B | -12.47 | 5.87B | 6.29B | 1 |
FQ3 2025 (Sep 2025) | 5.83B | -0.73 | 5.61B | 6B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 5.07 | 5.07 | 100% | |
FQ3 2024 (Sep 2024) | 3.26 | 3.26 | 100% | |
FQ2 2024 (Jun 2024) | 1.78 | 1.78 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.25 | 1.25 | 100% | |
FQ2 2023 (Jun 2023) | 0.0524 | 0.0524 | 100% | |
FQ1 2023 (Feb 2023) | 3.68 | 3.68 | 100% | |
FQ4 2022 (Dec 2022) | 3.61 | 3.61 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $6.81B | $6810.9M | 100% |
FQ3 2024 (Sep 2024) | $0B | $5.87B | $5868.8M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.63B | $5628.7M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $5.11B | $5111.4M | 100% |
FQ2 2023 (Jun 2023) | $0B | $5.05B | $5052.5M | 100% |
FQ1 2023 (Feb 2023) | $0B | $5.6B | $5604.8M | 100% |
FQ4 2022 (Dec 2022) | $0B | $5.6B | $5604.8M | 100% |